Apollo Therapeutics
Mel Glossop is currently the VP, Drug Discovery Program Leader at Apollo Therapeutics Limited, a venture between UK universities and pharmaceutical companies. Mel previously served as Project Director at Apollo Therapeutics LLP and Head of Chemistry at Centauri Therapeutics Limited, focusing on discovering novel molecules targeting life-threatening diseases. With a background in Chemistry, Mel has held various roles in the pharmaceutical industry, including Project Synthetic Leader and Principal Scientist at Pfizer.
Apollo Therapeutics
1 followers
Apollo Therapeutics provides funding & drug discovery expertise accelerating the best of British academic research to the clinic.